In 2022, the insurance industry faced several challenges, including limited funding, tighter budgets, and intense competition. This year, the industry’s growth is currently being hindered by inflation, causing higher claims costs and decreased demand.
Considering the macroeconomic headwinds, I think it is best to avoid insurance stocks Lemonade, Inc. (LMND), Hippo Holdings Inc. (HIPO), and Maiden Holdings, Ltd. (MHLD), which have declined in price over the past months.
